Skip to content
Subscribe
Follow Us
Subscribe
Follow Us
  • COMPANY
    • About Us
    • Team
  • Science
  • PIPELINE
    • Silvanex Antimicrobial Technology
    • Silvanex for Hospital Wound Care
    • Silvanex for Diabetic Ulcers
    • AND-259 for Breast Cancer
    • AND-254 for Mastectomy Pain
  • News
  • Contact
  • COMPANY
    • About Us
    • Team
  • Science
  • PIPELINE
    • Silvanex Antimicrobial Technology
    • Silvanex for Hospital Wound Care
    • Silvanex for Diabetic Ulcers
    • AND-259 for Breast Cancer
    • AND-254 for Mastectomy Pain
  • News
  • Contact

Jonathan Primer

Advisory Board

Read More

Dr. David Liu MBBS (Hons), BMedSc, PhD, FRACS, FAANZGOSA

Advisory Board

Read More

Ed Levy, PhD

Advisory Board

Read More
Load More
Andira Pharmaceuticals Inc. is a Vancouver-based biopharmaceutical company focused on the discovery and development of first-in-class cannabinoid therapeutics and medical devices to address unmet needs in infection control, post-surgical recovery, and early-stage breast cancer. Through collaborations with top-ranking academic and clinical partners, Andira aims to translate innovative science into practical healthcare solutions.

Explore

  • Company
  • Science
  • Pipeline
  • News

Contact Us

Investor Relations:

ir@andira.ca

Partnerships:

bd@andira.ca

General inquiries and media:

info@andira.ca

Follow our News & Announcements

Copyright © 2026 Andira Pharmaceuticals
Biotech website design